Read in the 10-K filed Feb 13, 2026We are also subject to various laws and regulations globally regarding cybersecurity, privacy and data protection, including laws and regulations relating to the collection, storage, handling, use, disclosure, transfer and security of personal data. The legislative and regulatory environment regarding privacy and data protection continues to evolve and receive significant attention globally. For example, we are subject to the EU’s GDPR and the California Consumer Privacy Act, as amended (CCPA), both of which impose comprehensive data protection obligations and provide for substantial penalties for noncompliance. Similar consumer privacy and data protection laws have been enacted or proposed in more than half of U.S. states, many of which impose obligations and restrictions that are comparable to, or in some cases more stringent than, those under the CCPA. Outside the United States, other jurisdictions where we operate have passed, or continue to propose, data
Privacy and data rules
521 of 1505 companies added a paragraph in Risk Factors that uses one of these words:
privacy, GDPR, personal data, personal information.
The paragraph is in the latest 10-K and nothing like it was in the one before.
It counts text; it does not say how serious a risk is. Words in capitals only (such as AI) must be in capitals.
By sector
Sector is the SEC's industry description of the company. The bar is the share of that sector's companies compared; each count opens that sector's quotes below.
- Rubber & Plastics Footwear 3 of 3
- Services-Personal Services 3 of 3
- Apparel & Other Finishd Prods of Fabrics & Similar Matl 2 of 2
- Ball & Roller Bearings 2 of 2
- Construction - Special Trade Contractors 2 of 2
- Dental Equipment & Supplies 2 of 2
- Retail-Miscellaneous Shopping Goods Stores 2 of 2
- Retail-Retail Stores, NEC 2 of 2
- Services-Detective, Guard & Armored Car Services 2 of 2
- Air Courier Services 1 of 1
- Carpets & Rugs 1 of 1
- Electric Lighting & Wiring Equipment 1 of 1
- Electronic Connectors 1 of 1
- Fabricated Structural Metal Products 1 of 1
- Footwear, (No Rubber) 1 of 1
- Functions Related To Depository Banking, NEC 1 of 1
- Gaskets, Packg & Sealg Devices & Rubber & Plastics Hose 1 of 1
- Hotels, Rooming Houses, Camps & Other Lodging Places 1 of 1
- Investors, NEC 1 of 1
- Meat Packing Plants 1 of 1
- Metal Doors, Sash, Frames, Moldings & Trim 1 of 1
- Miscellaneous Food Preparations & Kindred Products 1 of 1
- Motor Homes 1 of 1
- Radiotelephone Communications 1 of 1
- Retail-Drug Stores and Proprietary Stores 1 of 1
- Retail-Jewelry Stores 1 of 1
- Retail-Miscellaneous Retail 1 of 1
- Retail-Radio, Tv & Consumer Electronics Stores 1 of 1
- Retail-Shoe Stores 1 of 1
- Services-Advertising Agencies 1 of 1
- Services-Employment Agencies 1 of 1
- Services-Hospitals 1 of 1
- Services-Motion Picture & Video Tape Production 1 of 1
- Services-Offices & Clinics of Doctors of Medicine 1 of 1
- Services-Testing Laboratories 1 of 1
- Services-Video Tape Rental 1 of 1
- Tires & Inner Tubes 1 of 1
- Wholesale-Electrical Apparatus & Equipment, Wiring Supplies 1 of 1
- Wholesale-Hardware 1 of 1
- Wholesale-Misc Durable Goods 1 of 1
- Real Estate 5 of 6
- Men's & Boys' Furnishgs, Work Clothg, & Allied Garments 4 of 5
- Radio & Tv Broadcasting & Communications Equipment 3 of 4
- Services-Consumer Credit Reporting, Collection Agencies 3 of 4
- Orthopedic, Prosthetic & Surgical Appliances & Supplies 5 of 7
- Transportation Services 5 of 7
- Communications Services, NEC 4 of 6
- Computer Communications Equipment 2 of 3
- Computer Peripheral Equipment, NEC 2 of 3
- Cutlery, Handtools & General Hardware 2 of 3
- Electronic Computers 2 of 3
- Instruments For Meas & Testing of Electricity & Elec Signals 2 of 3
- Paints, Varnishes, Lacquers, Enamels & Allied Prods 2 of 3
- Services-Misc Health & Allied Services, NEC 2 of 3
- Telephone Communications (No Radiotelephone) 2 of 3
- Biological Products, (No Diagnostic Substances) 15 of 23
- Services-Computer Processing & Data Preparation 9 of 14
- Industrial Instruments For Measurement, Display, and Control 5 of 8
- Services-Prepackaged Software 50 of 81
- Services-Computer Programming, Data Processing, Etc. 11 of 18
- Other 6 of 10
- Computer Storage Devices 3 of 5
- Measuring & Controlling Devices, NEC 3 of 5
- Perfumes, Cosmetics & Other Toilet Preparations 3 of 5
- Finance Services 20 of 34
- Personal Credit Institutions 4 of 7
- Services-Educational Services 4 of 7
- Services-Medical Laboratories 4 of 7
- Investment Advice 13 of 26
- Surgical & Medical Instruments & Apparatus 11 of 22
- Services-Computer Integrated Systems Design 7 of 14
- Insurance Agents, Brokers & Service 6 of 12
- Oil & Gas Field Machinery & Equipment 3 of 6
- Cable & Other Pay Television Services 2 of 4
- Electronic & Other Electrical Equipment (No Computer Equip) 2 of 4
- Grain Mill Products 2 of 4
- Real Estate Agents & Managers (For Others) 2 of 4
- Retail-Eating & Drinking Places 2 of 4
- Savings Institution, Federally Chartered 2 of 4
- Services-Commercial Physical & Biological Research 2 of 4
- Services-General Medical & Surgical Hospitals, NEC 2 of 4
- Ship & Boat Building & Repairing 2 of 4
- Adhesives & Sealants 1 of 2
- Cigarettes 1 of 2
- Construction Machinery & Equip 1 of 2
- Drawing & Insulating of Nonferrous Wire 1 of 2
- Gas & Other Services Combined 1 of 2
- Leather & Leather Products 1 of 2
- Miscellaneous Manufacturing Industries 1 of 2
- Mortgage Bankers & Loan Correspondents 1 of 2
- Ophthalmic Goods 1 of 2
- Paper Mills 1 of 2
- Poultry Slaughtering and Processing 1 of 2
- Rolling Drawing & Extruding of Nonferrous Metals 1 of 2
- Services-Equipment Rental & Leasing, NEC 1 of 2
- Services-Health Services 1 of 2
- Special Industry Machinery, NEC 1 of 2
- Totalizing Fluid Meters & Counting Devices 1 of 2
- Wholesale-Computers & Peripheral Equipment & Software 1 of 2
- Wholesale-Lumber & Other Construction Materials 1 of 2
- Pharmaceutical Preparations 21 of 49
- Services-Miscellaneous Amusement & Recreation 2 of 5
- Services-To Dwellings & Other Buildings 2 of 5
- Real Estate Investment Trusts 33 of 84
- Hospital & Medical Service Plans 3 of 8
- State Commercial Banks 16 of 43
- Services-Business Services, NEC 13 of 37
- Motor Vehicle Parts & Accessories 5 of 15
- Chemicals & Allied Products 2 of 6
- Heavy Construction Other Than Bldg Const - Contractors 2 of 6
- Pipe Lines (No Natural Gas) 2 of 6
- Printed Circuit Boards 2 of 6
- Retail-Catalog & Mail-Order Houses 2 of 6
- Retail-Family Clothing Stores 2 of 6
- Services-Computer Programming Services 2 of 6
- Surety Insurance 2 of 6
- Bottled & Canned Soft Drinks & Carbonated Waters 1 of 3
- Calculating & Accounting Machines (No Electronic Computers) 1 of 3
- Computer & office Equipment 1 of 3
- Engines & Turbines 1 of 3
- General Industrial Machinery & Equipment, NEC 1 of 3
- Miscellaneous Chemical Products 1 of 3
- Refrigeration & Service Industry Machinery 1 of 3
- Retail-Auto & Home Supply Stores 1 of 3
- Retail-Building Materials, Hardware, Garden Supply 1 of 3
- Services-Engineering Services 1 of 3
- Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics 1 of 3
- Sporting & Athletic Goods, NEC 1 of 3
- Television Broadcasting Stations 1 of 3
- Wholesale-Groceries & Related Products 1 of 3
- Semiconductors & Related Devices 11 of 37
- National Commercial Banks 11 of 38
- Security Brokers, Dealers & Flotation Companies 4 of 14
- Trucking (No Local) 2 of 7
- Life Insurance 3 of 11
- Security & Commodity Brokers, Dealers, Exchanges & Services 2 of 8
- Accident & Health Insurance 1 of 4
- Air-Cond & Warm Air Heatg Equip & Comm & Indl Refrig Equip 1 of 4
- Aircraft 1 of 4
- Electromedical & Electrotherapeutic Apparatus 1 of 4
- Electronic Components & Accessories 1 of 4
- Misc Industrial & Commercial Machinery & Equipment 1 of 4
- Plastics Products, NEC 1 of 4
- Pumps & Pumping Equipment 1 of 4
- Retail-Lumber & Other Building Materials Dealers 1 of 4
- Services-Help Supply Services 1 of 4
- Services-Home Health Care Services 1 of 4
- Steel Works, Blast Furnaces & Rolling Mills (Coke Ovens) 1 of 4
- Fire, Marine & Casualty Insurance 7 of 30
- Retail-Auto Dealers & Gasoline Stations 3 of 13
- Retail-Eating Places 3 of 13
- Retail-Variety Stores 2 of 9
- Hotels & Motels 3 of 15
- Drilling Oil & Gas Wells 1 of 5
- Food and Kindred Products 1 of 5
- Industrial Organic Chemicals 1 of 5
- Mining & Quarrying of Nonmetallic Minerals (No Fuels) 1 of 5
- Miscellaneous Fabricated Metal Products 1 of 5
- Refuse Systems 1 of 5
- Services-Amusement & Recreation Services 1 of 5
- Services-Management Consulting Services 1 of 5
- Water Supply 1 of 5
- Air Transportation, Scheduled 1 of 6
- Electric Services 4 of 26
- Beverages 1 of 7
- Laboratory Analytical Instruments 1 of 7
- Petroleum Refining 1 of 7
- Plastic Materials, Synth Resins & Nonvulcan Elastomers 1 of 7
- Crude Petroleum & Natural Gas 3 of 23
- Motor Vehicles & Passenger Car Bodies 1 of 8
- Operative Builders 1 of 9
- Natural Gas Transmission 1 of 10
964 paragraphs · Biological Products, (No Diagnostic Substances) show all sectors
Read in the 10-K filed Feb 26, 2026We also may be subject to international privacy and data protection laws, such as the General Data Protection Regulation (“GDPR”) in the European Economic Area (“EEA”) and similar legislation in the United Kingdom and
Read in the 10-K filed Feb 12, 2026We may use, and our vendors may incorporate, artificial intelligence, or AI, both in our own development and implementation of AI and through the adoption of commercially available tools. The use of AI presents risks and challenges that could adversely affect our business and reputation, including cybersecurity, data privacy, IT, confidentiality, regulatory, legal, operational, competitive, reputational, intellectual property and other risks. Specifically, risks related to accuracy, bias, AI hallucinations, discrimination, harmful content, misinformation, fraud, scams, targeted attacks (including model poisoning or data poisoning), surveillance, data leakage, bias and inequality, environmental and other harms may flow from our development or use of AI technologies. For example, use of certain AI tools may lead to false or misleading information being used, relied upon or referenced by us or our vendors. Furthermore, use of certain AI tools may increase the risk of unauthorized disclosure of confidential information, compromise of proprietary intellectual property, or inadvertent inclusion of third-party intellectual property or other protected material, which could result in disputes or claims of infringement.
Read in the 10-K filed Feb 12, 2026We could be subject to risks caused by misappropriation, misuse, leakage, falsification of data, records or other information, encryption through ransomware, or intentional or accidental release or loss of information maintained in the information systems and networks of our company and our vendors, including personal information of our employees and study subjects, and company and vendor confidential data. These attacks and activity are also being facilitated or enhanced by evolving technologies, including AI. In addition, outside parties may attempt to penetrate our systems or those of our vendors or fraudulently induce our personnel or the personnel of our vendors to disclose sensitive information in order to gain access to our data and/or systems. Like other companies in the industry, we, and our third-party vendors, have experienced threats and cybersecurity incidents relating to our information technology infrastructure, data and systems, and may experience threats and cybersecurity incidents in the future. The number and
Read in the 10-K filed Feb 17, 2026Additionally, artificial intelligence (“AI”) based software is increasingly being used in the biopharmaceutical industry including by companies with which we compete. We are increasing the use of AI tools and technology and intend to integrate AI more broadly in our operations with the goal of increasing operational efficiencies, improve cycle times and improve decision-making, thus strengthening our ability to compete. The integration of third-party AI technology with our operations relies on certain safeguards implemented by the third-party developers of the underlying AI technology including those related to security and the accuracy, bias and other variables of the data, and these safeguards may not be sufficient to mitigate the risks associated with the use of AI. Furthermore, the use of AI based software may result in cybersecurity incidents and lead to the inadvertent release of personal information or other confidential proprietary information, which may impact our ability to realize the benefit of our intellectual property. Governments have passed laws and are likely to pass additional laws regulating the use of generative AI. Our use of this technology could result in compliance costs, regulatory investigations and actions, and lawsuits. If we are unable to use generative AI due to any of the risks associated with such use, it could make our business less efficient and result in competitive disadvantages.
Read in the 10-K filed Feb 17, 2026In the United States, federal, state, and local governments have enacted numerous data privacy and security laws, including data breach notification laws, personal information privacy laws, consumer protection laws, and other similar laws. Notably, HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, imposes requirements on covered entities, as well as their business associates regarding the privacy, security, and transmission of individually identifiable health information.
Read in the 10-K filed Feb 26, 2026third-party vendors’ information systems from malicious third parties or insider threats may incorporate widely varying and frequently changing tactics, which may be enhanced or facilitated by artificial intelligence. Any failure to prevent or mitigate security breaches or improper access to, use of, or disclosure of our clinical data or patients’ personal data could result in significant liability under state (e.g., state breach notification laws), federal (e.g., HIPAA, as amended by HITECH), and international law (e.g., the EU General Data Protection Regulation, or GDPR) and may cause a material adverse impact to our reputation, affect our ability to use collected data, conduct new studies and potentially disrupt our business.
Read in the 10-K filed Feb 26, 2026The GDPR also imposes strict rules on the transfer of personal data to countries outside of the UK and EEA that do not ensure an adequate level of protection, including the United States in certain circumstances, unless derogation exists or a valid GDPR transfer mechanism (for example, the European Commission approved Standard Contractual Clauses (SCCs) and the UK International Data Transfer Agreement or Addendum (UK IDTA)) have been put in place, and transfer impact assessments conducted. The EU and U.S. have adopted its adequacy decision for the EU-U.S. Data Privacy Framework, or Framework, which entered into force on July 11, 2023. This Framework provides that the protection of personal data transferred between the EU and the United States is comparable to that offered in the EU. This provides a further avenue to ensuring transfers to
Read in the 10-K filed Feb 26, 2026the United States are carried out in line with GDPR. There has been an extension to the Framework to cover UK transfers to the United States. The Framework could be challenged like its predecessor frameworks. Any inability to transfer personal data from the UK or EEA to the United States in compliance with data protection laws may impede our operations and may adversely affect our business and financial position.
Read in the 10-K filed Feb 20, 2026In the United States, at the federal level, failing to take appropriate steps to keep consumers’ personal information secure may constitute unfair acts or practices in or affecting commerce in violation of Section 5(a) of the Federal Trade Commission Act. In addition, numerous states have introduced comprehensive laws which govern the privacy and security of personal information. For example, California has passed the CCPA and more than a dozen other states have passed their own similar comprehensive consumer privacy laws. Other states proposed or passed laws that target particular aspects of privacy, including health, genetic and biometric information, which could have particular impact for our business. For example, Washington passed a law that protects the privacy of consumer health-related information that is not covered by HIPAA and includes a private right of action. In addition, state laws such as the Texas Genomic Privacy Act and others focus specifically on genetic information and could materially impact our business.
Read in the 10-K filed Feb 20, 2026Regulators and legislators are also increasingly scrutinizing and restricting certain personal data transfers and transactions involving foreign countries. For example, the Department of Justice’s January 8, 2025, rule on “Preventing Access to U.S. Sensitive Personal Data and Government-Related Data by Countries of Concern or Covered Persons,” prohibits data brokerage transactions involving certain sensitive personal data categories, including health data, genetic data, and biospecimens, to countries of concern, including China. The regulations also restrict certain investment agreements, employment agreements and vendor agreements involving such data and countries of concern, absent specified cybersecurity controls. Actual or alleged violations of these rules may be punishable by criminal and/or civil sanctions, result in exclusion from participation in federal and state programs or restrict our ability to use certain vendors, sites, investigators, or service providers in global clinical trials.
Read in the 10-K filed Feb 20, 2026The integration of AI Technologies into our and our vendors’ systems (potentially without the vendor disclosing such use to us) subjects us to the risk that the providers of AI Technologies may not meet existing or evolving legal, regulatory or industry standards relating to privacy, data protection, cybersecurity, intellectual property, product safety, human oversight, or algorithmic accountability. Compliance with these requirements may require substantial investments in governance, documentation, monitoring, testing, or operational controls, and may limit our ability to deploy or scale certain AI-enabled tools or features.
Read in the 10-K filed Feb 11, 2026Additionally, the DOJ issued a rule entitled the Preventing Access to U.S. Sensitive Personal Data and Government-Related Data by Countries of Concern or Covered Persons, which places additional restriction on certain data transactions involving countries of concern (e.g., China, Russia, Iran) and covered persons (i.e., individuals and entities who are designated as such by the U.S. Attorney General or considered “foreign persons” and are majority owned by, organized under the laws of, a primary resident in, or a contractor of, a covered person or country of concern, as applicable) that may impact certain business activities such as vendor engagements, sale or sharing of data, employment of certain individuals, and investor agreements. Violations of the rule could lead to significant civil and criminal fines and penalties. The rule applies regardless of whether data is anonymized, key-coded, pseudonymized, de-identified or encrypted, which presents particular challenges for companies like ours and may impact our ability to engage in certain transactions or agreements.
Read in the 10-K filed Feb 26, 2026We plan to build and integrate AI into our business practices, and the evolving nature of AI technologies and the surrounding legal and regulatory environment presents risks and uncertainties that could affect our business. The use of AI technology can give rise to intellectual property risks, including the disclosure or compromise of our confidential information or other proprietary intellectual property through the use of generative artificial intelligence tools. AI could also pose cybersecurity, data privacy, IT, regulatory, legal, operational, competitive, reputational, and other risks and challenges that could affect our business. Specifically, risks related to bias, AI hallucinations, discrimination, harmful content, misinformation, fraud, scams, targeted attacks such as model poisoning or data poisoning, surveillance, data leakage, loss of consensus reality, inequality, environmental harms, and other harms may flow from our development, use, or deployment of AI technologies. Additionally, we expect to see increasing government regulation related to artificial intelligence use and ethics, which may also significantly increase the burden and cost of research, development and compliance in this area. For example, in the U.S., a number of states have proposed or passed dozens of laws over the past year regulating various uses and applications of AI and AI governance, including addressing deployment of AI in healthcare settings. At the federal level, the Trump Administration has endorsed a federal moratorium on enforcement of certain state-level AI regulation,
Read in the 10-K filed Feb 25, 2026processing of personal information could result in negative publicity, government investigations and enforcement actions, claims by third parties and damage to our reputation.
Read in the 10-K filed Feb 25, 2026We use artificial intelligence (AI), machine learning, and automated decision-making technologies (collectively, AI Technologies) throughout our business, and are making investments in this area. We expect that increased investment will be required in the future to continuously improve our use of AI Technologies. As with many technological innovations, there are significant risks involved in developing, maintaining and deploying these technologies, including that AI-generated content, analyses, or recommendations we utilize could be deficient, that our competitors may more quickly or effectively adopt AI capabilities, or that our use of AI or other emerging technologies increases regulatory, cybersecurity and other significant risks. In addition, the use of certain AI Technologies, including third-party solutions, may involve the input, processing or storage of proprietary, confidential or personal information, and any failure to appropriately protect such information, or any unauthorized disclosure or use of such information, could adversely affect our business, harm our reputation and subject us to liability. There can be no assurance that the usage of or our investments in such technologies will always enhance our products or services or be beneficial to our business, including our efficiency or profitability.
Read in the 10-K filed Mar 3, 2026The GDPR also imposes strict rules on the transfers of personal data outside of the EEA or the UK to third countries, such as the US in certain circumstances, unless a derogation exists or a valid GDPR transfer mechanism (for example, the European Commission approved standard contractual clauses (“SCCs”) and the UK International Data Transfer Agreement/Addendum (“UK IDTA”)). Where relying on the SCCs or UK IDTA for data transfers, we may also be required to carry out transfer impact assessments to assess whether the recipient is subject to local laws which allow public authority access to personal data. The complexity and the additional contractual burden increases our overall risk exposure. There may be further divergence on international transfer safeguards in the future, including with regard to administrative burdens. Any inability to transfer personal data from the UK and EEA to the US (and other third countries) in compliance with data protection laws may adversely affect our operations and our business and financial position. The UK data protection regime is independent from but currently still aligned with the EEA’s data protection regime. However, going forward, there will be increasing scope for divergence in application, interpretation and enforcement of the data protection law as between the UK and EEA. Although the UK is regarded as a third country under the EU GDPR, the European Commission has issued a decision recognizing the UK as providing adequate protection under the EU GDPR and, therefore, transfers of personal data originating in the EEA to the UK remain unrestricted. Similarly, the UK government has confirmed that personal data transfers from the UK to the EEA remain free flowing. However, the UK Data (Use and Access) Act 2025 now in force, may further differentiate the UK’s data protection regimes and could potentially impact the UK’s adequacy decision granted by the European Commission. The respective provisions and enforcement of the EU GDPR and UK GDPR may continue to diverge, creating additional regulatory challenges and uncertainty. This evolving regulatory landscape could increase legal risk, complexity and cost to our handling of personal data, and may require us to adapt our privacy and data security compliance programs to account for increasing legal and regulatory divergence between the UK and the EEA.
Read in the 10-K filed Feb 23, 2026A further example of comprehensive and evolving regulatory requirements is data privacy regulations surrounding personal data and protected health information including the EU’s General Data Protection Regulation, or GDPR, which imposes strict requirements on controllers and processors of personal data, including special protections for “special category data,” which includes health, biometric and genetic information of data subjects located in the EEA and UK. Further, the GDPR provides a broad right for EEA Member States to create supplemental national laws, such as laws relating to the processing of health, genetic and biometric data, which could further limit our ability to use and share such data or could cause our costs to increase, and harm our business and financial condition. Furthermore, there are evolving European privacy laws on electronic marketing and cookies.
Read in the 10-K filed Aug 24, 2026our operations or the operations of our customers and partners, delay production and shipments, result in theft of our and our customers’ intellectual property and trade secrets, result in disclosure of personally identifiable information, damage customer, patient, business partner and employee relationships and our reputation and result in defective products or services, legal claims and proceedings, liability and penalties under privacy laws and increased costs for security and remediation, in each case resulting in an adverse effect on our business and financial results.
Read in the 10-K filed Nov 17, 2025We are subject to data privacy and data protection laws, rules, and customer-imposed controls as a result of producing, collecting, processing, storing and transmitting confidential, personal and/or sensitive data in the course of our business. A significant number of countries where we operate have enacted privacy or data protection laws, rules and regulations, creating significant compliance challenges as we seek to maintain our global reach. In some cases, there are restrictions on the transfer of personal data outside the home country. More recently, privacy and data protection regulators are paying special attention to emerging issues linked to new digital technologies, such as the use of AI, biometrics, and surveillance technologies, which pose unique challenges to existing privacy and data protection paradigms. Any actual or perceived noncompliance could result in significant consequences, including, business interruption, sanctions and significant pecuniary fines, regulatory inquiries and investigations, adverse publicity, loss of competitive advantage and customer trust, as well as privacy litigation and civil lawsuits with damages, any of which may adversely affect our business, reputation and financial statements.
Read in the 10-K filed Feb 26, 2026•multiple, conflicting and changing laws and regulations such as tax laws, privacy and data protection laws and regulations, export and import restrictions, employment laws, regulatory requirements and other governmental approvals, permits and licenses;